products are clinically proven to relieve heartburn within 30 to 60 minutes, and the relief lasts up to 12 hours, adds Holz, noting that the active ingredient, ranitidine, has been prescribed by doctors "to effectively treat and prevent heartburn for millions of patients.
A spokesman for Zantac
makers GlaxoSmithKline said: "All the products we produce have been put through extensive clinical trials and approved by licensing bodies.
which acquired the Zantac
line in 2006, now ranks as a powerhouse in the digestives market.
The plunge in the sales of Zantac
75 may be explained in part by consumers' preference for the higher-strength Zantac
150, for which sales increased by nearly 7 % over the past year, according to IRI.
It did have a setback last year when Zantac
lost its protection from competition and sales dropped severely.
Glaxo Wellcome was hit after patents ran out for Zantac
, allowing cheaper rivals to muscle in.
Pfizer responded to the approval of Prilosec for OTC use today stating that the difference between Zantac
75 and Prilosec OTC is simple: Zantac
75 relieves heartburn fast.
Another big winner in the category in 2006 was Boehringer-Ingelheim's Zantac
150 antacid, another switched product, which ranked No.
revenue from six top-selling products, including Glaxo's blockbuster ulcer drug, Zantac
already a leader in the segment with Dulcolax, a leading laxative, expanded its role in the antacid segment late last year with its acquisition of Zantac
from Johnson & Johnson and Pfizer Consumer Healthcare Inc.
P&G), Prilosec, which vaulted nearly 32%; Johnson & Johnson's third-ranked Zantac
150, which soared 93%; and No.
With its 2006 acquisition of Zantac
over-the-counter products in the United States, the Boehringer Ingelheim Consumer Health C are (CHC) division of Boehringer Ingelheim Pharmaceuticals Inc.
One of those medicines, Johnson & Johnson's Zantac
, is moving to a new home as a result of J&J's acquisition of Pfizer Inc.
Some of the prominent brand names within Pfizer's HBA product portfolio are: Listerine, Plax, Efferdent, Sudafed, Benadryl, Sinutab, Neosporin, Cortizone, Ben-Gay, Zantac
, and Rolaids.
Most of the leading brands, including Zantac
and Tagamet, have been under pressure as consumers have opted in larger numbers for lower-price private label alternatives, which together grew nearly 13% to total $135.